Related Experiment Video
Updated: Jun 12, 2025

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
Published on: August 2, 2017
Cardiovascular burden of individuals diagnosed with idiopathic hypersomnia: Real-World Idiopathic Hypersomnia Total
Ragy Saad1, Prasheel Lillaney1, Deb A Profant1
1Jazz Pharmaceuticals, 3170 Porter Drive, Palo Alto, CA, 94304, USA.
Insights
Individuals with idiopathic hypersomnia face significantly higher cardiovascular risks, including heart disease and stroke. This highlights the need for careful monitoring and management of cardiovascular health in these patients.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Idiopathic hypersomnia (IH) is a rare sleep disorder with limited research on its association with cardiovascular risk.
- Understanding the cardiovascular implications of IH is crucial for comprehensive patient care.
Purpose of the Study:
- To compare the prevalence of cardiovascular conditions and events in individuals diagnosed with idiopathic hypersomnia versus matched controls without the condition.
- To quantify the increased odds of specific cardiovascular outcomes in the IH population.
Main Methods:
- A retrospective analysis of claims data from Merative™ MarketScan® Research Databases (12/2013-2/2020) was conducted.
- Cohorts of individuals with idiopathic hypersomnia (n=11,412) and matched controls (n=57,058) were established based on specific inclusion criteria.
- Unconditional logistic regression was used to compare the odds of prevalent cardiovascular conditions over a 2-year period.
Main Results:
- Individuals with idiopathic hypersomnia exhibited significantly higher odds of numerous cardiovascular conditions.
- These included cardiovascular disease (OR 2.26), major adverse cardiovascular events (OR 2.08), stroke (OR 2.07), hypertension (OR 2.02), heart failure (OR 1.97), and myocardial infarction (OR 1.74).
Conclusions:
- The study demonstrates a substantially elevated risk of prevalent cardiovascular conditions and events in individuals with idiopathic hypersomnia.
- These findings underscore the importance for clinicians to consider the cardiovascular risk profile of patients when managing idiopathic hypersomnia.
Objective/Background:
Limited research assesses cardiovascular risk in people with idiopathic hypersomnia. This study compared cardiovascular conditions or events among individuals with idiopathic hypersomnia with those among matched non-idiopathic hypersomnia controls.
Patients/Methods:
Claims from Merative™ MarketScan® Research Databases (12/2013-2/2020) were analyzed. Eligible individuals with idiopathic hypersomnia were ≥18 years of age upon cohort entry, continuously enrolled for 365 days before and after cohort entry (gaps ≤30 days allowed), and without cataplexy. Individuals with idiopathic hypersomnia entered the cohort upon their earliest medical claim with an idiopathic hypersomnia diagnosis code. Controls were matched 5:1, without replacement, to individuals with idiopathic hypersomnia using demographic characteristics. Odds of prevalent cardiovascular conditions or events during the 2-year assessment period (365 days before and after cohort entry date) were compared using unconditional logistic regression. Results were reported as odds ratios (ORs) with 95 % confidence intervals (CIs).
Results:
Final cohorts included 11,412 individuals with idiopathic hypersomnia and 57,058 matched controls. Odds (OR, 95 % CI) of cardiovascular disease (2.26, 2.14-2.38), major adverse cardiovascular event (2.08, 1.89-2.30), stroke (2.07, 1.87-2.29), hypertension diagnosis or antihypertensive use (2.02, 1.93-2.12), heart failure (1.97, 1.76-2.20), atrial fibrillation (1.91, 1.66-2.20), myocardial infarction (1.74, 1.42-2.12), and coronary revascularization (1.58, 1.12-2.17) were higher in individuals with idiopathic hypersomnia than matched controls.
Conclusions:
Individuals with idiopathic hypersomnia had higher odds of prevalent cardiovascular conditions or events than matched controls. These results reinforce that clinicians should be aware of patients' cardiovascular risk profiles when selecting idiopathic hypersomnia treatments.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Management of Insomnia
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Hypertension II: Pathophysiology

